ScienceMag reported on a new five-year, $3.9 million National Cancer Institute grant awarded to UCLA’s Cristina Puig-Saus and her research team to develop new strategies to improve cancer immunotherapy. The researchers, based at the UCLA Health Jonsson Comprehensive Cancer Center, have created a fast, large-scale drug-screening platform to identify compounds that help T cells better recognize and destroy cancer cells. The work initially focuses on melanoma, but the approach could be expanded to other cancers. Read more about UCLA in today’s Washington Post, Los Angeles Times and others.